MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-AS-16-0001232
Criceto Pharmaceuticals Private Limited
Criceto Pharmaceuticals Private Limited - pharma in Guwahati, Assam, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.36 Cr
▲ 43% YoY
Net profit · FY 2025
₹3.69 Lakh
Net margin 2.7%
EBITDA · FY 2025
₹5.12 Lakh
EBITDA margin 3.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹25 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
4
As per MCA filings
About Criceto Pharmaceuticals Private Limited
Data last updated:
Criceto Pharmaceuticals Private Limited is a private limited company based in Guwahati, Assam, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24290AS2021PTC021111. Its GSTIN is 18AAJCC3424G1ZS (Assam).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rimi Paul and Chandrima Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Subrata Banerjee Bhaskar Nagar 4th Bye Lane Ward No 16, Guwahati, Assam, India – 781002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.36 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹3.69 Lakh (net margin 2.7%) and EBITDA of ₹5.12 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 92% over three years.
As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
Criceto Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AS-16-0001232).
Company details
CIN U24290AS2021PTC021111
Registration Number 021111
Incorporation Date 10 March 2021
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-AS-16-0001232
Recognitions & Rankings of Criceto Pharmaceuticals
Contact details
Criceto Pharmaceuticals Private Limited's registered office is in Guwahati, Assam. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Subrata Banerjee Bhaskar Nagar 4th Bye Lane Ward No 16, Guwahati, Assam, India – 781002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Criceto Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Criceto Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Criceto Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Criceto Pharmaceuticals Private Limited, buy the company report.
Financials of Criceto Pharmaceuticals Private Limited
FY 2025 filings availableCriceto Pharmaceuticals Private Limited reported revenue of ₹1.36 Cr (up 43% YoY) for FY 2025.
Revenue · FY 2025
₹1.36 Cr ▲ 43%
Net profit · FY 2025
₹3.69 Lakh margin 2.7%
EBITDA · FY 2025
₹5.12 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 92%
EBITDA CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 71%
Revenue has grown at a compounded annual rate (CAGR) of 92% over three years, including 43% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.69 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Criceto Pharmaceuticals Private Limited, buy the company report.
Board of directors of Criceto Pharmaceuticals Private Limited
Criceto Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rimi Paul | Director | 10 Mar 2021 | 5 Years 7 Months | Current |
| Chandrima Banerjee | Director | 10 Mar 2021 | 5 Years 7 Months | Current |
| Jaydip Bhowmick | Director | 15 Jul 2023 | 3 Years 3 Months | Current |
| Subrata Banerjee | Director | 15 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Criceto Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sierra Pharmaceuticals Limited. | ₹1.38 Cr (FY 2024) | -11.0% | New Delhi, Delhi, India | |||
| Vilexo Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 7.0% | Delhi, India | |||
| Mencure Pharmaceuticals Private Limited | ₹1.37 Cr (FY 2024) | 12.0% | Patna, Bihar, India | |||
| Criceto Pharmaceuticals Private Limitedthis company | ₹1.36 Cr (FY 2025) | ₹3.69 Lakh | 2.7% | 43.0% | Guwahati, Assam, India |
To see the full peer comparison of Criceto Pharmaceuticals Private Limited, buy the company report.
Auditor
Criceto Pharmaceuticals Private Limited is audited by PANKAJ KUMAR SHARMA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PANKAJ KUMAR SHARMA & CO. | FY 2023 | 331735E |
Shareholding
The shareholding of Criceto Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Criceto Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jun 2025 | 101138058 | Others | ₹25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Criceto Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Guwahati | Company petition | Filed against the company by an individual | Disposed |
To see the full case history of Criceto Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Criceto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Criceto Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 10, 2024.
Active EPFO establishments
1
GST
Criceto Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AAJCC3424G1ZS | Assam | Active | 08 Apr 2021 |
To see the full GST registrations and return filing status of Criceto Pharmaceuticals Private Limited, buy the company report.
Recent activity
Criceto Pharmaceuticals Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Jaydip Bhowmick was appointed as Director on 15 Jul 2023.
AGM
Criceto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 101138058 was registered on 26 Jun 2025.
Filing
Criceto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Appointed
Jaydip Bhowmick was appointed as Director.
Appointed
Subrata Banerjee was appointed as Director.
Appointed
Chandrima Banerjee was appointed as Director.
Appointed
Rimi Paul was appointed as Director.
Incorporation
10 Mar 2021
Criceto Pharmaceuticals Private Limited was registered on 10 Mar 2021 with Roc Guwahati & aged 5 years 7 months as per MCA records.
Frequently asked questions
Criceto Pharmaceuticals is an active private limited company based in Guwahati, Assam, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 March 2021 (5+ years old) and is registered under CIN U24290AS2021PTC021111.
Criceto Pharmaceuticals has 4 current directors:
- Rimi Paul - Director
- Chandrima Banerjee - Director
- Jaydip Bhowmick - Director
- Subrata Banerjee - Director
The latest financial statements of Criceto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Criceto Pharmaceuticals is 18AAJCC3424G1ZS, registered in Assam.
The CIN (Corporate Identification Number) of Criceto Pharmaceuticals is U24290AS2021PTC021111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Criceto Pharmaceuticals has 1 court case on record: 1 filed against it.
Criceto Pharmaceuticals was incorporated on 10 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Criceto Pharmaceuticals by revenue are Sierra Pharmaceuticals Limited, Vilexo Pharmaceuticals Private Limited, Mencure Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Jaydip Bhowmick was appointed as Director on 15 Jul 2023. Subrata Banerjee was appointed as Director on 15 Jul 2023. Chandrima Banerjee was appointed as Director on 10 Mar 2021. Criceto Pharmaceuticals has 4 board changes on record in total.
Yes, Criceto Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AS-16-0001232).
The registered office of Criceto Pharmaceuticals is at CO Subrata Banerjee Bhaskar Nagar 4th Bye Lane Ward No 16, Guwahati, Assam, India – 781002.